- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about LLY
Recent news which mentions LLY
Billionaire Investor Stanley Druckenmiller Dumps Broadcom, Bets Big On Tesla, Amazon And Other Big Tech Stocks In Q4
February 18, 2025
From Benzinga
Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors
February 17, 2025
From Benzinga
3 Stocks That Could Trounce the Market in 2025
February 17, 2025
From Motley Fool
Think Eli Lilly's Stock Is Expensive? Here's Why Selling It Now Could Be a Huge Mistake
February 15, 2025
Tickers
LLY
From Motley Fool
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
February 14, 2025
From Benzinga
GLP-1 Drugs Drive Growth for Eli Lilly. Is the Stock a Buy?
February 13, 2025
Tickers
LLY
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
February 12, 2025
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 11, 2025
From Benzinga
Eli Lilly Seeks To Expand Into Cancer Radiopharma And Fatty Liver, With Two Global Deals
February 10, 2025
From Benzinga
5 ETFs That Beat Market Turmoil With Gains Last Week
February 10, 2025
From Benzinga
2 Growth Stocks to Buy Hand Over Fist in February
February 09, 2025
From Motley Fool
Is Novo Nordisk Stock a Buy Now?
February 08, 2025
From Motley Fool
Down 65%, Is Viking Therapeutics Stock a Buy on the Dip?
February 08, 2025
From Motley Fool
Magnificent Seven Slip, Inflation Fears Grip Consumers, Gold Hits Record Highs: This Week In The Markets
February 07, 2025
From Benzinga
Eli Lilly's Recently Approved Inflammatory Bowel Disease Drug Shows Sustained And Durable Treatment At Two Years
February 07, 2025
From Benzinga
Stocks Edge Higher, Bank Giants Rally, Palantir Skyrockets: What's Driving Markets Thursday?
February 06, 2025
From Benzinga
Trump Focused On 10-Year Yield And Not On The Fed, Slower AI Growth Fears Weigh On Arm Stock
February 06, 2025
From Benzinga
The 9 Best Stocks to Buy Now in February (2025)
February 06, 2025
From Motley Fool
Eli Lilly Q4 Earnings: Strong Demand For Mounjaro But Prices Dip, Forecasts Over 30% Jump In 2025 Sales On Newer Medicines
February 06, 2025
From Benzinga
US Stocks Likely To Open Higher Ahead Of Amazon's Earnings: 'Buy The Dip' Mentality Remains Prevalent, Says Analyst
February 06, 2025
From Benzinga
Earnings Scheduled For February 6, 2025
February 06, 2025
From Benzinga
Eli Lilly Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
February 06, 2025
From Benzinga
Eli Lilly Bulls Take Charge Ahead Of Q4 — Can It Reach $1000?
February 05, 2025
Tickers
LLY
From Benzinga
What To Expect When Eli Lilly Reports Q4 Earnings On Thursday?
February 05, 2025
From Benzinga
Novo Nordisk Faces Investor Concerns Over Hybrid CagriSema Trial Results For Weight Loss
February 04, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.